Tetratherix Limited

Company Profile

Sector

Healthcare

Industry

Biotechnology

Employees

15

Website

tetratherix.com

Country

Australia

Exchange

ASX

Tetratherix provides biomaterial and regenerative medicine business in Australia and globally. The company manufactures and commercialize medical device in the areas of bone regeneration, tissue spacing, and tissue healing applications through its Tetramatrix platform technology. Tetratherix Limited was incorporated in 2015 and is based in Alexandria, Australia.

Key Stats

52-Week Range

A$3.09A$7.70

BetaN/A

Trailing P/EN/A

Forward P/E-49.50

Trailing EPS-0.40

Avg Volume

Earnings & Analyst

Next EarningsN/A

EPS EstimateN/A

Target Mean PriceA$6.12

RecommendationBuy

Recommendation Mean2.00

Recent SEC Filings

SEC filings for this ticker are not available yet.